Meredith H. Boerschlein

Meredith has been involved in all stages of U.S. district court litigation, from pre-litigation diligence and initial pleadings through trial and post-trial. Her experience includes analyzing patent portfolios for assertion; formulating claim construction, infringement, and validity positions; conducting fact and expert discovery; drafting briefs and motion materials; preparing fact and expert witnesses; taking and defending depositions; and examining fact witnesses at trial.

In addition to her litigation work, Meredith counsels clients on issues arising under patent and Food and Drug Administration (FDA) law, leveraging her corporate experience working in regulatory affairs for a microbiology company. In this role, Meredith ensured regulatory compliance of studies involving pharmaceuticals and medical devices, while also coordinating compliance activities for clients and regulatory agencies. Her graduate studies concentrated on the intersection of innovative biotechnology, regulatory affairs, and patent law.

Meredith chairs the AIPLA Biotechnology Quarterly Call Committee, organizing quarterly presentations on patent law issues impacting the biotechnology sector. She also serves as an adjunct professor at the George Mason University Antonin Scalia Law School, teaching a seminar on patent litigation.

Meredith’s pro bono practice includes immigration law and wrongful convictions. She has been repeatedly recognized on the Capital Pro Bono Honor Roll.